Genmab — April 2023
-
vd Winkel mentioned that keeping the Genmab culture ingrained during this time of expansion was one of his main challenges https://ashfieldeventex.com/case-study/employee-engagement-event-genmab/
-
BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors https://www.globenewswire.com/news-release/2023/04/03/2639380/0/en/BioNTech-and-DualityBio-Form-Global-Strategic-Partnership-to-Accelerate-Development-of-Differentiated-Antibody-Drug-Conjugate-Therapeutics-for-Solid-Tumors.html -With this collaboration, ADCs will become an additional drug class in BioNTech’s oncology portfolio
-
Har denne været vist. US salgs tal for feb
-
Fornuftige Darzalex salg
Darzalex-salg i USA fra Symphony Health for februar var på USD
466 mio. mod 439 mio. i januar, svarende til en årlig vækst på
35% mod 33,6% for 2022. Det indikerer et salg på USD 5,7 mia.
for 2023, hvor markedet forventer et salg på USD 5,3 mia. i USA.
Darzalex FasPro leverede fint med en vækst på 12,6%, mens
Darzalex leverede 5,8% og konkurrenten Sarclisa en vækst på
15,8%. FasPro udgør nu 87,4% af det samlede salg (op fra 76% i
starten af 2022) -
@Pensionisten kl 22:55 og 22:52 Så du mener at Genmabs ledelse kender udfaldet af voldgiftssagen og de derfor har valgt som de har gjort? Så en lang behandlingstid er = med at det er svært at formulere og forsvare deres afgørelse?
-
thanks @troldmanden ; the last SH data we got was last year May....
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
